Literature DB >> 26418969

Structural phase transitions in trigonal Selenium induce the formation of a disordered phase.

Anirban Pal1, Smita Gohil, Surajit Sengupta, H K Poswal, Surinder M Sharma, Shankar Ghosh, Pushan Ayyub.   

Abstract

Arguments based on the Mermin-Wagner theorem suggest that the quasi-1D trigonal phase of Se should be unstable against long wavelength perturbations. Consisting of parallel Se-Se chains, this essentially fragile solid undergoes a partial transition to a monoclinic structure (consisting of 8-membered rings) at low temperatures (≈50 K), and to a distorted trigonal phase at moderate pressures (≈3GPa). Experimental investigations on sub-millimeter-sized single crystals provide clear evidence that these transitions occur via a novel and counter-intuitive route. This involves the reversible formation of an intermediate, disordered structure that appears as a minority phase with increasing pressure as well as with decreasing temperature. The formation of the disordered state is indicated by: (a) a 'Boson-peak' that appears at low temperatures in the specific heat and resonance Raman data, and (b) a decrease in the intensity of Raman lines over a relatively narrow pressure range. We complement the experimental results with a phenomenological model that illustrates how a first order structural transition may lead to disorder. Interestingly, nanocrystals of trigonal Se do not undergo any structural transition in the parameter space studied; neither do they exhibit signs of disorder, further underlining the role of disorder in this type of structural transition.

Entities:  

Year:  2015        PMID: 26418969     DOI: 10.1088/0953-8984/27/41/415404

Source DB:  PubMed          Journal:  J Phys Condens Matter        ISSN: 0953-8984            Impact factor:   2.333


  1 in total

1.  Negative linear compressibility in Se at ultra-high pressure above 120 GPa.

Authors:  Shuhua Yuan; Luhong Wang; Sheng-Cai Zhu; Fuyang Liu; Dongzhou Zhang; Vitali B Prakapenka; Sergey Tkachev; Haozhe Liu
Journal:  IUCrJ       Date:  2022-02-01       Impact factor: 4.769

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.